Thailand to sell generic Viagra drug: officials

September 26, 2012

Thailand has approved an affordable generic version of the anti-impotence drug Viagra to go on sale next week, as the country looks to combat rampant counterfeit production, officials said Wednesday.

The Thai diamond-shaped little blue pill, which resembles the original produced by US pharmaceutical giant , is called "Sidegra" and will be available on prescription across the country on October 1.

Priced at 25 baht (80 US cents) per pill, Thailand's (FDA) said it will be ten times cheaper than full-price Viagra.

"This measure will solve widespread production of by increasing accessibility to the legal version," FDA secretary general Pipat Yingseree said in a statement.

The release said Pfizer had since looked to discount its pills by 30 percent to "cooperate with the government on curbing fake drugs".

"Pfizer is selling at a discount to be able to compete with our Sidegra," said an official at the state-run Government Pharmaceutical Organisation, which is producing the drug.

No one from Pfizer's offices in Thailand was available for comment.

An FDA official said the US company's patent to produce the anti-impotence had expired in Thailand.

Fake sex drugs are openly on sale on street stalls targeting tourists around the red light districts of the Thai capital.

In a raid on a Bangkok warehouse in July, Thai police seized several hundred thousand purported sex enhancement and aphrodisiac pills and a large haul of sex toys, worth an estimated $3.2 million.

Explore further: S. Korea to approve Viagra generics

Related Stories

S. Korea to approve Viagra generics

March 14, 2012
Three South Korean pharmaceutical firms will soon be allowed to produce generic versions of the anti-impotence drug Viagra despite a row over patents, officials said Wednesday.

Internet led to global 'explosion' of fake drugs

June 14, 2012
The rapid growth of Internet commerce has led to an explosion of counterfeit drugs sold around the world, with China the biggest source of fake medicines, pharmaceutical experts said Thursday.

US approves India's Ranbaxy to make generic Lipitor

December 1, 2011
Indian pharmaceutical giant Ranbaxy won US regulatory approval to make the first generic version of cholesterol lowering drug Lipitor, a Pfizer product whose patent expired Wednesday.

China arrests nearly 2,000 in fake drug crackdown

August 6, 2012
(AP) — China's Ministry of Public Security says it has detained nearly 2,000 people in a nationwide crackdown on counterfeit drugs, including some to treat cancer.

Recommended for you

Drug for spinal muscular atrophy prompts ethical dilemmas, bioethicists say

December 11, 2017
When the Food and Drug Administration approved the first drug for people with spinal muscular atrophy a year ago, clinicians finally had hope for improving the lives of patients with the rare debilitating muscular disease. ...

FDA's program to speed up drug approval shaved nearly a year off the process

December 7, 2017
Speeding the pace at which potentially lifesaving drugs are brought to market was a rallying cry for Donald Trump as a candidate, and is a stated priority of his Food and Drug Administration commissioner, Dr. Scott Gottlieb. ...

Dangers of commonly prescribed painkillers highlighted in study

December 6, 2017
Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed.

Viagra goes generic: Pfizer to launch own little white pill

December 6, 2017
The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first ...

Surgery-related opioid doses can drop dramatically without affecting patients' pain

December 6, 2017
Some surgeons might be able to prescribe a third of opioid painkiller pills that they currently give patients, and not affect their level of post-surgery pain control, a new study suggests.

Four-fold jump in deaths in opioid-driven hospitalizations

December 4, 2017
People who end up in the hospital due to an opioid-related condition are four times more likely to die now than they were in 2000, according to research led by Harvard Medical School and published in the December issue of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.